Methods and apparatus for transpericardial left atrial appendage closure

Information

  • Patent Grant
  • 8721663
  • Patent Number
    8,721,663
  • Date Filed
    Tuesday, June 14, 2011
    13 years ago
  • Date Issued
    Tuesday, May 13, 2014
    10 years ago
Abstract
Methods and apparatus for closing a left atrial appendage are described. The methods rely on introducing a closure tool from a location beneath the rib cage, over an epicardial surface, and to the exterior of the left atrial appendage. The closure device may then be used to close the left atrial appendage, preferably at its base, by any one of a variety of techniques. A specific technique using graspers and a closing loop is illustrated.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to medical methods and apparatus. More particularly, the present invention relates to a method and device for the minimally invasive closure of a left atrial appendage of the heart.


Atrial fibrillation is a common cardiac rhythm disorder affecting a population of approximately 2.5 million patients in the United States alone. Atrial fibrillation results from a number of different causes and is characterized by a rapid chaotic heart beat. In addition to the risks associated with a disordered heart beat, patients with atrial fibrillation also have an increased risk of stroke. It has been estimated that approximately 75,000 atrial fibrillation patients each year suffer a stroke related to that condition. It appears that strokes in these patients result from emboli many of which may originate from the left atrial appendage. The irregular heart beat causes blood to pool in the left atrial appendage, allowing clots to accumulate over time. From time to time, clot may dislodge from the left atrial appendage and may enter the cranial circulation causing a stroke, the coronary circulation causing a myocardial infarction, the peripheral circulation causing limb ischemia, as well as other vascular beds.


Significant efforts have been made to reduce the risk of stroke in patients suffering from atrial fibrillation. Most commonly, those patients are treated with blood thinning agents, such as coumadin, to reduce the risk of clot formation. While such treatment can significantly reduce the risk of stroke, it also increases the risk of bleeding and for that reason is inappropriate for many atrial fibrillation patients.


As an alternative to drug therapy, surgical procedures for closing the left atrial appendage have been proposed. Most commonly, the left atrial appendage has been closed or removed in open surgical procedures, typically where the heart has stopped and the chest opened through the sternum. Because of the significant risk and trauma of such procedures, left atrial appendage removal occurs almost exclusively when the patient's chest is opened for other procedures, such as coronary artery bypass or valve surgery.


For that reason, alternative procedures which do not require opening of the patient's chest, i.e., a large median sternotomy, have been proposed. U.S. Pat. No. 5,306,234 to Johnson describes a thoracoscopic procedure where access to the pericardial space over the heart is achieved using a pair of intercostal penetrations (i.e., penetrations between the patient's ribs) to establish both visual and surgical access. While such procedures may be performed while the heart remains beating, they still require deflation of the patient's lung and that the patient be placed under full anesthesia. Furthermore, placement of a chest tube is typically required to reinflate the lung, often requiring a hospitalization for a couple of days.


U.S. Pat. No. 5,865,791, to Whayne et al. describes a transvascular approach for closing the left atrial appendage. Access is gained via the venous system, typically through a femoral vein, a right internal jugular vein, or a subclavian vein, where a catheter is advanced in an antegrade direction to the right atrium. The intra-atrial septum is then penetrated, and the catheter passed into the left atrium. The catheter is then positioned in the vicinity of the left atrial appendage which is then fused closed, e.g., using radiofrequency energy, other electrical energy, thermal energy, surgical adhesives, or the like. Whayne et al. further describes a thoracoscopic procedure where the pericardium is penetrated through the rib cage and a lasso placed to tie off the neck of the left atrial appendage. Other fixation means described include sutures, staples, shape memory wires, biocompatible adhesives, tissue ablation, and the like. The transvascular approach suggested by Whayne et al. is advantageous in that it avoids the need to penetrate the patient's chest but suffers from the need to penetrate the intra-atrial septum, may not provide definitive closure, requires entry into the left atrial appendage which may dislodge clot and requires injury to the endocardial surface which may promote thrombus formation. A thoracoscopic approach which is also suggested by Whayne et al. suffers from the same problems as the thoracoscopic approach suggested by Johnson.


For all these reasons, it would be desirable to provide improved and alternative methods and procedures for performing minimally invasive closure of the left atrial appendage. Such methods and procedures will preferably be capable of being performed on patients who have received only a local anesthetic and whose hearts have not been stopped. It would be further desirable to provide methods and procedures which approach the left atrial appendage without the need to perform a thoracotomy (penetration through the intracostal space) or the need to perform a transeptal penetration and/or perform the procedure within the left atrium or left atrial appendage. More specifically, it would be preferable to provide methods and procedures which permitted access to the pericardial space from the xiphoid region of a patient's chest. In addition to the improved and alternative methods and procedures, it would be desirable to provide specialized instruments, devices, and systems for accessing a region over a patient's left atrial appendage from a sub-xiphoid access point to permit closure of the left atrial appendage.


At least some of these objectives will be met by the inventions described herein below.


2. Description of the Background Art


U.S. Pat. Nos. 5,306,234 and 5,865,791 have been described above. U.S. Pat. No. 3,496,932 and PCT publication WO 98/05289 describe methods and apparatus which employ a sub-xiphoid approach for direct cardiac massage.


SUMMARY OF THE INVENTION

The present invention provides alternative and improved methods and apparatus for closing a left atrial appendage of a patient, particularly a patient at risk of occlusive stroke resulting from emboli released from the left atrial appendage. The most likely patient population for the procedures will be patients suffering from atrial fibrillation which can result in clot and thrombus generation in the left atrial appendage, as described above. The methods and apparatus of the present invention permit procedures to be performed on a conscious sedated patient, often in an ambulatory surgical setting where the patient may be released shortly after the procedure is completed. In particular, the methods and apparatus of the present invention eliminates the need for a large incision and division of the sternum, i.e., median sternotomy. The present invention further eliminates the need to take down (deflate) a lung to access a left atrial appendage, as is usually required in thoracoscopic procedures performed via intracostal access.


The methods of the present invention will be performed in a minimally invasive manner, i.e., where access to the pericardial space overlying the patient's left atrial appendage is accomplished through percutaneous penetrations through the patient's skin. Rather than passing through the rib cage, as with prior thoracoscopic techniques, the present invention relies on a “sub-xiphoid” approach where the percutaneous penetration is first made beneath the rib cage, preferably between the xiphoid and adjacent costal cartilage, and an atrial appendage closure tool advanced through the penetration, over the epicardial surface (in the pericardial space) to reach a location adjacent to the exterior of the left atrial appendage. The closure tool can then be used to close the left atrial appendage to prevent the formation of clot and the release of emboli from the atrium.


Closure can be effected in a variety of ways. It is presently preferred to position a loop of material, such as suture, wire, mesh, tape, or the like, over the appendage and cinch the loop tighter to close the interior of the appendage. A variety of alternative closure techniques would also find use, including suturing (using remotely actuated suturing instruments), stapling, clipping, fusing, gluing, clamping, riveting, or the like. Such closure will generally be intended to be permanent, i.e., it will remain indefinitely after the closure tool is removed, but in some instances could be reversible, i.e., the left atrial appendage could be reopened on a subsequent procedure.


Thus, a method according to the present invention for closing a left atrial appendage of a patient's heart comprises positioning a closure instrument through a percutaneous passage beneath the rib cage, over an epicardial surface, and adjacent to the left atrial appendage. The left atrial appendage is then closed, usually using one of the techniques described above. The positioning step may comprise making an incision usually between a costal cartilage and a xiphoid of the patient, establishing a tract beneath the rib cage. Alternatively the incision may be made superficial to the xiphoid or sternum after which a tract is made through the rib cage to the pericardial space, and will preferably include placing an access sheath through the incision into the pericardial space. The incision may be made using a scalpel or other conventional surgical tool, but could also be made using a trocar and cannula assembly, such as those used in laparoscopic surgery, where the trocar could then be removed leaving the cannula in place as the sheath of the present invention. Use of a trocar and cannula may be less preferred, however, since there is an increased risk of injuring the heart if the trocar and cannula assembly is introduced in a blind fashion.


A closure instrument is then introduced through the sheath into the pericardial space, and over an epicardial surface to the exterior of the left atrial appendage, as described above. Preferably, a distal end of the tool will be introduced into an atrioventricular groove which lies just beneath the atrial appendage.


Preferably, once the closure tool has been introduced, advancement and positioning can be performed under conventional imaging techniques, such as fluoroscopic imaging. Often, the closure tool will include or be compatible with imaging scopes which may be introduced through the tool. The use of imaging scopes will be particularly useful during the closure procedure where the left atrial appendage is manipulated as described in more detail below. In such instances, it will frequently be desirable to introduce a saline or other clear fluid into the pericardial space to facilitate viewing.


Once the closure tool is properly positioned, closure may be effected by any of the techniques described above, including looping, suturing, stapling, clipping, fusing, clamping, riveting, or the like. Preferably, the closure will be directed at the base region of the left atrial appendage. Optionally, closing the appendage may further comprise grasping the exterior of the left atrial appendage prior to the actual closing step. Grasping will typically be performed with the conventional grasping tool. As described below, a preferred closure technique is to first grasp the exterior of the left atrial appendage with a grasping tool and subsequently advance a closure loop over the tool on to the exterior of the appendage. A closure loop may then be cinched or otherwise closed or allowed to close, and the tools removed.


A variety of specific instruments, devices, and systems may be devised for performing the methods of the present invention. An exemplary device for closing a left atrial appendage according to the methods of the present invention is described in detail in the descriptions that follow. The device comprises a shaft having a proximal end and a distal end, where the distal end is adapted to percutaneously enter the pericardial space, be advanced over en epicardial surface, and then approach the exterior of the left atrial appendage. Preferably, the shaft has a length in the range from 10 cm to 40 cm, a width in the range from 2 mm to 20 mm, and a thickness in the range from 1 mm to 10 mm. Usually, the shaft will be curved over its length to be compatible with the curvature of the heart. The shaft may include a means to alter the curvature to accommodate variations in anatomy. Similarly, the device may preferably include a crescent-shaped cross-section to also conform to the shape of the exterior of the heart. The device will carry a mechanism or means for closing the left atrial appendage when the distal end of the shaft is positioned adjacent to the appendage. Usually, the closure mechanism will be introducable through one or more lumens formed in the shaft. In a particularly preferred configuration, the distal end of the shaft will be configured to lie within the atrioventricular groove of the heart, and at least one lumen through the shaft will have an exit port spaced inwardly from the distal end of the shaft by a distance in the range from 0.5 cm to 5 cm. In this way, the port will be positioned properly to access the free end of the atrial appendage for performing the closing procedures. In addition, the shaft may have one or more additional lumens (for a total of two, three, or more lumens through the shaft) in order to provide additional capabilities, including introduction and use of a viewing scope, infusion and perfusion of fluids, particularly the infusion of saline to facilitate viewing. Optionally, the lumens can be used to introduce an anesthetic agent, such as lidocaine, in order to reduce pain or to introduce an anti-arrhythmic agent to reduce myocardial irritability.


The present invention still further comprises kits including the closure devices just described. The kits will further include instructions for use according to the methods described above, and optionally further include packaging for holding all components of the kit together. Additionally, the kits may include the access sheath which is placed through the percutaneous penetration tracks as the pericardial space. The access sheath may be in the form of a trocar and cannula assembly, although this will usually not be preferred.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an anterior view of a heart illustrating the position of the left atrial appendage relative to the remaining structures of the heart.



FIG. 2 shows the position of the heart in an associated chest cavity and illustrates a preferred percutaneous access site for performing the methods of the present invention.



FIG. 3 is a perspective view of an exemplary closure tool useful for performing the methods of the present invention.



FIGS. 4A-4C are orthogonal views of the closure device of FIG. 3.



FIG. 5 illustrates an access sheath placed percutaneously into a pericardial space using a sub-xiphoid approach beneath the rib cage as is preferred in the methods of the present invention.



FIGS. 6A-6G illustrate use of the exemplary tool of FIG. 3 in performing the closure of a left atrial appendage according to the methods of the present invention. FIGS. 6H-6J show a closure device having an additional lumen and introduced so that its distal end enters the atrioventricular groove.



FIGS. 6K-6N illustrate an alternative protocol for use of the exemplary tool of FIG. 3 in performing the closure of a left atrial appendage according to the methods of the present invention.



FIGS. 6O and 6P illustrate alternative clip placement patterns for closing the left atrial appendage according to the methods of the present invention.



FIG. 7A-7C illustrate an exemplary clip which may be used in performing the closure methods of the present invention.



FIG. 8 illustrates a clip insertion tool useful for placing the clip of FIGS. 7A-7C according to the methods of the present invention.



FIGS. 9A-9C are cross-sectional views of the insertion tool of FIG. 8 used in placing the clip of FIG. 7A-7C over a left atrial appendage according to the methods of the present invention.



FIG. 10 illustrates an exemplary kit including a closure device and optional components according to the present invention.





DESCRIPTION OF THE SPECIFIC EMBODIMENTS


FIG. 1 is an anterior view of a heart illustrating the right ventricle RV, the left ventricle LV, and the left atrial appendage LAA. The methods and apparatus of the present invention are intended to place a closure structure over or otherwise close off the base region BR of the left atrial appendage. By closing off the base region BR, the exchange of materials between the left atrial appendage LAA and the left atrium LA will be stopped. Thus, the release of emboli from the left atrial appendage into the left atrium will be stopped.


Referring now to FIG. 2, the heart is located within the pericardial space PS located beneath the patient's rib cage RC. The sternum S is located in the center of the rib cage RC and terminates at its lower end in the xiphoid X. On either side of the xiphoid are the costal cartilage CC, and the percutaneous access points for performing the procedures of the present invention will be located beneath the rib cage RC, and preferably between the xiphoid X and an adjacent costal cartilage CC, preferably at the access location AL shown by a broken line.


An exemplary tool 10 for performing the methods of the present invention is illustrated in FIGS. 3, 3A, and 4A-4C. The tool comprises a shaft 12 having a distal end 14 and a proximal end 16. A handle 18 is preferably attached to the proximal end of the shaft, and the shaft will have a curved profile in its axial direction (as best seen in FIG. 4B) and a crescent-shaped cross-section, as best seen in FIG. 4C. The preferred dimensions of the shaft are set forth above.


In the illustrated embodiment, the shaft has three lumens 20, 22, and 24. A first lumen 20 is used for introducing a closure tool (which may be any of the closure tools described above), while the second and third lumens (22 and 24, respectively) are used for introducing a viewing scope and fluids, such as saline or other clear fluids for improving visualization of the region surrounding the left atrial appendage. In alternative embodiments, the first lumen 20 can still be used for a grasper, while either of the second lumen 22 and/or third lumen 24 may be used for introducing alternative closure devices, such as clip appliers, riveting devices, fusing devices, suturing devices, stapling devices, or the like. In a particular embodiment shown below, either or both of the lumens 22 and 24 may be used to advance a clip over the left atrial appendage as the appendage is being grasped by a grasper, such as the one shown in FIG. 3.


While the closure tool may have any of a wide variety of designs, the presently preferred tool is shown in FIG. 3A. The tool comprises a grasper 30 and a capture loop 32. Capture loop 32 is attached to a manipulation wire 34 which permits the loop 32 to be advanced over the forward end of the grasper to encircle and close the left atrial appendage, as will be described in more detail below. The grasping tool 30 may be manipulated using a thumb guide 40, while the capture loop 32 may be manipulated using a second thumb guide 42, both of which are located on the handle 18.


The lumens 20, 22, and 24, terminate in exit ports 50, 52, and 54, best seen in FIG. 4A. The exit ports are located proximally of the distal end 14 of the shaft 12. The shaft is generally thinned in the region between the exit ports and the distal tip, facilitating the introduction of the distal tip into the atrioventricular groove, as described in more detail below. The exit ports are located a sufficient distance behind the distal tip of the shaft so that they will be generally located adjacent to the free end of the left atrial appendage when the tip is located in the atrioventricular groove.


The methods of the present invention may be performed in an ambulatory surgical setting. Typically, a sedated patient is taken to a facility having fluoroscopic imaging capabilities. The area overlying the xiphoid and adjacent costal cartilage, is prepared and draped using standard techniques. A local anesthetic is then administered and a skin incision, usually about 2 cm in length made, at the area shown in FIG. 2. The percutaneous penetration passes beneath the costal cartilage, and a sheath 100 (FIG. 5) is introduced into the pericardial space PS. The pericardial space PS is then irrigated with saline, preferably with a saline-lidocaine solution to provide additional anesthesia and reduce the risk of irritating the heart. The closure device 10 is then introduced through the sheath 100 into the pericardial space and advanced over the epicardium to the atrioventricular groove AVG (as shown in FIG. 6A and FIG. 6B). The grasping tool 30 is then advanced distally from the tool 10 so that it can grasp the free end of the left atrial appendage LAA, as shown in FIG. 6C. A slight tension can be applied on the left atrial appendage LAA as the capture loop 32 is advanced over the grasper 30 (FIG. 6D), and on to the left atrial appendage LAA, as shown in FIG. 6E. The loop may then be cinched, as shown in FIG. 6F, and the tool 10 withdrawn leaving the closure loop in place, as shown in FIG. 6G. The interior of the left atrial appendage LAA is thus isolated from the interior of the left atrium so that thrombus and other emboli cannot be released into blood circulation.


Optionally, a portion of the parietal pericardium may be further separated from the epicardial surface and the left atrial appendage prior to closing the appendage. Increasing the distance between the parietal and visceral pericardium, i.e., the pericardial space, creates a working and viewing space that facilitates subsequent manipulation and closure of the atrial appendage. As shown in FIGS. 6H-6J, a modified closure device 100 having an additional lumen 102 is introduced so that its distal end 104 enters the atrioventricular groove AVG, as described previously. A balloon expander 110 may then be introduced through the lumen 102, and the balloon expanded to raise the pericardium, as shown in FIG. 6I. The grasper 30 (or other closure instrument) may then be introduced through other lumens, as previously described. The working space created by the balloon greatly simplifies manipulation and positioning of the graspers 30 so that they can be used to capture the atrial appendage and close it as described previously. Further separating the parietal and visceral pericardia to create the working space is a particular advantage when a viewing scope is introduced to the working area to facilitate manipulation of the grasper 30 and any other tools which may be used.


Referring now to FIGS. 6K-6N, the closure tool 10 is illustrated in a method for introducing a clip 200 in accordance with the principles of the present invention. The closure tool 10 is introduced to the left atrial appendage LAA as described in above in connection with FIGS. 6A and 6B. Once in place, the clip 200 may be introduced through any of the available lumens in the device, typically using a pusher 202. The clip 200 will be configured so that it opens as it emerges from the closure tool 10 and can be advanced over the free distal end of the left atrial appendage LAA, as shown in FIG. 6L. The clip 200 may then be closed over the appendage, as shown in FIG. 6N. The clip 200 may be self-closing or may require a mechanical or heat-actuated closure mechanism. Once in place, as shown in FIG. 6N, the closure tool 10 can be removed. Frequently, it will be desirable to introduce multiple clips 200, as shown in FIG. 6O. Alternatively, a larger clip 208 can be introduced transversely over the left atrial appendage LAA, as shown in FIG. 6P.


Referring now to FIGS. 7A-7C, an exemplary clip 300 for use in the methods of the present invention will be described. The clip 300 has a generally U-shaped profile, as best seen in FIG. 7A, optionally having a serpentine or zig-zag profile on at least one of the legs of the clip. As illustrated, a series of peaks and valleys 302 is provided on an “upper” leg of the clip. The clip 300 further includes a hinge region 304 which has a narrowed width to facilitate introduction through a introducer catheter 400, as shown in FIG. 8. Introducer catheter 400 bag a I-shaped lumen 402 which receives the clip 300 so that the upper leg and lower leg of the clip are held in an open configuration in upper and lower tracks of the lumen, as described below in connection with FIGS. 9A-9C. Optionally, the catheter 400 may include a radiopaque marker 404 to permit orientation under fluoroscopic imaging (so the position can confirm that the clip is in the proper vertical orientation when being placed). A pusher 408 is provided having a I-shaped distal end 410 which is received in the I-shaped lumen 402 in order to advance and eject the clip from the catheter.


Referring now to FIGS. 9A-9C, the clip 300 is held in the lumen 402 of catheter 400 with the legs of the clip held open. A pusher 408 can be advanced so that end 410 engages the hinge region 304 of the clip, allowing it to be advanced out of the distal end of the catheter, as shown in FIG. 9B. As the clip 300 emerges, it remains in an open configuration so that it can be advanced over a free distal end of the left atrial appendage LAA, as shown in FIG. 9B. Once the clip 300 is fully advanced and released from the catheter 400, as shown in FIG. 9C, the clip will close over the left atrial appendage LAA to hold the appendage closed in accordance with the principles of the present invention.


Referring now to FIG. 10, kits according to the present invention comprise a closure tool, such as closure tool 10 described above. Optionally, the kits may comprise an access sheath 120 and will include instructions for use IFU setting forth any of the methods described above. Usually, all components of the kit will be packaged together in an enclosure 140, such as a pouch, tray, box, tube, or other conventional surgical package capable of maintaining the components in a sterile condition. It will be appreciated that any kit containing instructions for use setting forth the methods of the present invention will be part of the present invention. Whether or not the kits include a closure device which is similar to FIG. 10 is not necessary.


While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.

Claims
  • 1. A method for closing the left atrial appendage comprising: advancing a sheath into the pericardial space using a percutaneous approach;advancing a tissue grasper through the sheath;grasping the left atrial appendage with the grasper;advancing a loop over the tissue grasper to encircle the left atrial appendage;tightening the loop to close the left atrial appendage.
  • 2. The method of claim 1 further comprising advancing an expandable member into the pericardial space and expanding the expandable member to raise a portion of the pericardium.
  • 3. The method of claim 2 wherein the expandable member comprises a balloon.
  • 4. The method of claim 1 wherein the method is visualized using fluoroscopic imaging.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of application Ser. No. 11/944,522, filed Nov. 23, 2007, which is a continuation of application Ser. No. 10/105,978, filed Mar. 25, 2002, now U.S. Pat. No. 7,318,829, which is a division of application Ser. No. 10/007,364, filed Nov. 5, 2001, now U.S. Pat. No. 7,226,458, which is a division of application Ser. No. 09/315,601, filed May 20, 1999, now U.S. Pat. No. 6,488,689, each of which is hereby incorporated by reference in their entirety.

US Referenced Citations (406)
Number Name Date Kind
1376754 Fulton May 1921 A
1468599 Longino Sep 1923 A
2131321 Hart Sep 1938 A
3496932 Prisk et al. Feb 1970 A
3677597 Stipek Jul 1972 A
3703169 Ouchi Nov 1972 A
3802074 Hoppe Apr 1974 A
3820544 Semm Jun 1974 A
3841685 Kolodziej Oct 1974 A
3871379 Clarke Mar 1975 A
3896793 Mitsui et al. Jul 1975 A
3999555 Person Dec 1976 A
4018229 Komiya Apr 1977 A
4030509 Heilman et al. Jun 1977 A
4078305 Akiyama Mar 1978 A
4181123 Crosby Jan 1980 A
4190042 Sinnreich Feb 1980 A
4217891 Carson Aug 1980 A
4249536 Vega Feb 1981 A
4257278 Papadofrangakis et al. Mar 1981 A
4280510 O'Neill Jul 1981 A
4319562 Crosby Mar 1982 A
4369768 Vukovic Jan 1983 A
4579348 Jones Apr 1986 A
4596530 McGlinn Jun 1986 A
4662377 Heilman et al. May 1987 A
4706655 Krauter Nov 1987 A
4744363 Hasson May 1988 A
4759348 Cawood Jul 1988 A
4765341 Mower et al. Aug 1988 A
4798593 Iwatschenko Jan 1989 A
4817608 Shapland et al. Apr 1989 A
4841949 Shimizu et al. Jun 1989 A
4865037 Chin et al. Sep 1989 A
4901405 Grover et al. Feb 1990 A
4909789 Taguchi et al. Mar 1990 A
4934340 Ebling et al. Jun 1990 A
4935027 Yoon Jun 1990 A
4944753 Burgess et al. Jul 1990 A
4991578 Cohen et al. Feb 1991 A
4991603 Cohen et al. Feb 1991 A
4998975 Cohen et al. Mar 1991 A
5033477 Chin et al. Jul 1991 A
5071428 Chin et al. Dec 1991 A
5108406 Lee Apr 1992 A
5144942 Decarie et al. Sep 1992 A
5163942 Rydell Nov 1992 A
5163946 Li Nov 1992 A
5163949 Bonutti Nov 1992 A
5176691 Pierce Jan 1993 A
5181123 Swank Jan 1993 A
5226535 Rosdhy et al. Jul 1993 A
5226908 Yoon Jul 1993 A
5230705 Wilk Jul 1993 A
5234455 Mulhollan Aug 1993 A
5242459 Buelna Sep 1993 A
5243977 Trabucco et al. Sep 1993 A
5250054 Li Oct 1993 A
5267968 Russo Dec 1993 A
5267970 Chin et al. Dec 1993 A
5269326 Verrier Dec 1993 A
5281238 Chin et al. Jan 1994 A
5300078 Buelna Apr 1994 A
5306234 Johnson Apr 1994 A
5318527 Hyde et al. Jun 1994 A
5318578 Hasson Jun 1994 A
5336231 Adair Aug 1994 A
5336252 Cohen Aug 1994 A
5361895 Wilson et al. Nov 1994 A
5366446 Tal et al. Nov 1994 A
5373840 Knighton Dec 1994 A
5382238 Abrahamson et al. Jan 1995 A
5385156 Oliva Jan 1995 A
5387219 Rappe Feb 1995 A
5403331 Chesterfield et al. Apr 1995 A
5405351 Kinet et al. Apr 1995 A
5417684 Jackson et al. May 1995 A
5417697 Wilk et al. May 1995 A
5423821 Pasque Jun 1995 A
5423830 Schneebaum et al. Jun 1995 A
5433457 Wright Jul 1995 A
5433730 Alt Jul 1995 A
5443481 Lee Aug 1995 A
5449637 Saito et al. Sep 1995 A
5494240 Waugh Feb 1996 A
5498228 Royalty et al. Mar 1996 A
5520701 Lerch May 1996 A
5540711 Kieturakis et al. Jul 1996 A
5545138 Fugosa et al. Aug 1996 A
5569290 McAfee Oct 1996 A
5582580 Buckman, Jr. et al. Dec 1996 A
5591177 Lehrer Jan 1997 A
5609597 Lehrer Mar 1997 A
5624430 Eton et al. Apr 1997 A
5624453 Ahmed Apr 1997 A
5634895 Igo et al. Jun 1997 A
5653716 Malo et al. Aug 1997 A
5656012 Sienkiewicz Aug 1997 A
5676162 Larson, Jr. et al. Oct 1997 A
5676651 Larson, Jr. et al. Oct 1997 A
5678547 Faupel et al. Oct 1997 A
5681278 Igo et al. Oct 1997 A
5682906 Sterman et al. Nov 1997 A
5683364 Zadini et al. Nov 1997 A
5683445 Swoyer Nov 1997 A
5693059 Yoon Dec 1997 A
5693091 Larson, Jr. et al. Dec 1997 A
5699748 Linskey, Jr. et al. Dec 1997 A
5702430 Larson, Jr. et al. Dec 1997 A
5707336 Rubin Jan 1998 A
5716367 Koike et al. Feb 1998 A
5716392 Bourgeois et al. Feb 1998 A
5725521 Mueller Mar 1998 A
5727569 Benetti et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735877 Pagedas Apr 1998 A
5741281 Martin Apr 1998 A
5752526 Cosgrove May 1998 A
5766151 Valley et al. Jun 1998 A
5766189 Matsuno Jun 1998 A
5766216 Gangal et al. Jun 1998 A
5766217 Christy Jun 1998 A
5766687 Rappoport Jun 1998 A
5769848 Wattanasirichaigoon Jun 1998 A
5769863 Garrison Jun 1998 A
5779727 Orejola Jul 1998 A
5792112 Hart et al. Aug 1998 A
5792151 Heck et al. Aug 1998 A
5792177 Kaseda Aug 1998 A
5797870 March et al. Aug 1998 A
5797929 Andreas et al. Aug 1998 A
5797946 Chin Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5800414 Cazal Sep 1998 A
5810845 Yoon Sep 1998 A
5814021 Balbierz Sep 1998 A
5823946 Chin Oct 1998 A
5827216 Igo et al. Oct 1998 A
5840059 March et al. Nov 1998 A
5843146 Cross, Jr. Dec 1998 A
5855586 Habara et al. Jan 1999 A
5861005 Kontos Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5871531 Struble Feb 1999 A
5873876 Christy Feb 1999 A
5879375 Larson, Jr. et al. Mar 1999 A
5882299 Rastegar et al. Mar 1999 A
5895298 Faupel et al. Apr 1999 A
5897586 Molina Apr 1999 A
5900433 Igo et al. May 1999 A
5906620 Nakao et al. May 1999 A
5906626 Carrillo May 1999 A
5908429 Yoon Jun 1999 A
5908435 Samuels Jun 1999 A
5910124 Rubin Jun 1999 A
5910129 Koblish et al. Jun 1999 A
5921993 Yoon Jul 1999 A
5921994 Andreas et al. Jul 1999 A
5924424 Stevens et al. Jul 1999 A
RE36269 Wright Aug 1999 E
5931787 Dietz et al. Aug 1999 A
5941819 Chin Aug 1999 A
5946688 Roberts Aug 1999 A
5947953 Ash et al. Sep 1999 A
5957936 Yoon et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5964699 Rullo et al. Oct 1999 A
5968010 Waxman et al. Oct 1999 A
5972013 Schmidt Oct 1999 A
5984866 Rullo et al. Nov 1999 A
5984917 Fleischman et al. Nov 1999 A
5991668 Leinders et al. Nov 1999 A
5997525 March et al. Dec 1999 A
6006122 Smits Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6015382 Zwart et al. Jan 2000 A
6045561 Marshall et al. Apr 2000 A
6059750 Fogarty et al. May 2000 A
6067942 Fernandez May 2000 A
6071281 Burnside et al. Jun 2000 A
6081738 Hinohara et al. Jun 2000 A
6083153 Rullo et al. Jul 2000 A
6090042 Rullo et al. Jul 2000 A
6095968 Snyders Aug 2000 A
6110170 Taylor et al. Aug 2000 A
6120431 Magovern et al. Sep 2000 A
6132438 Fleischman et al. Oct 2000 A
6148230 KenKnight Nov 2000 A
6149595 Seitz et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6152936 Christy et al. Nov 2000 A
6155968 Wilk Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6161543 Cox et al. Dec 2000 A
6162195 Igo et al. Dec 2000 A
6167889 Benetti Jan 2001 B1
6199556 Benetti et al. Mar 2001 B1
6200303 Verrior et al. Mar 2001 B1
6206004 Schmidt et al. Mar 2001 B1
6210416 Chu et al. Apr 2001 B1
6221007 Green Apr 2001 B1
6224584 March et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6237605 Vaska et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6258021 Wilk Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6280415 Johnson Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6292630 Yokonuma Sep 2001 B1
6293906 Vanden Hoek et al. Sep 2001 B1
6296630 Altman et al. Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6311693 Sterman et al. Nov 2001 B1
6312404 Agro et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6319201 Wilk Nov 2001 B1
6333347 Hunter et al. Dec 2001 B1
6338737 Toledano Jan 2002 B1
6340356 Navia et al. Jan 2002 B1
6346074 Roth Feb 2002 B1
6352503 Matsui et al. Mar 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6423051 Kaplan et al. Jul 2002 B1
6461330 Miyagi Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6485407 Alferness et al. Nov 2002 B2
6488664 Solomon et al. Dec 2002 B1
6488689 Kaplan et al. Dec 2002 B1
6494211 Boyd et al. Dec 2002 B1
6511488 Marshall et al. Jan 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6561969 Frazier et al. May 2003 B2
6592552 Schmidt Jul 2003 B1
6610055 Swanson et al. Aug 2003 B1
6610072 Christy et al. Aug 2003 B1
6613062 Leckrone et al. Sep 2003 B1
6616674 Schmieding Sep 2003 B2
6632229 Yamanouchi Oct 2003 B1
6652555 VanTassel et al. Nov 2003 B1
6656175 Francischelli et al. Dec 2003 B2
6666861 Grabek Dec 2003 B1
6692491 Phan Feb 2004 B1
6709415 Navia et al. Mar 2004 B2
6723107 Skiba et al. Apr 2004 B1
6733486 Lee et al. May 2004 B1
6733509 Nobles et al. May 2004 B2
6736774 Benetti et al. May 2004 B2
6755338 Hahnen et al. Jun 2004 B2
6786898 Guenst Sep 2004 B2
6789509 Motsinger Sep 2004 B1
6830174 Hillstead et al. Dec 2004 B2
6830576 Fleischman et al. Dec 2004 B2
6855137 Bon Feb 2005 B2
6932813 Thompson et al. Aug 2005 B2
6985776 Kane et al. Jan 2006 B2
6994092 Van der Burg et al. Feb 2006 B2
7011671 Welch Mar 2006 B2
7041111 Chu May 2006 B2
7044134 Khairkhahan et al. May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7063682 Whayne et al. Jun 2006 B1
7063693 Guenst Jun 2006 B2
7112172 Orban, III et al. Sep 2006 B2
7128073 Van der Burg et al. Oct 2006 B1
7135018 Ryan et al. Nov 2006 B2
7166099 Devens, Jr. Jan 2007 B2
7169156 Hart Jan 2007 B2
7175619 Koblish et al. Feb 2007 B2
7186214 Ness Mar 2007 B2
7207988 Leckrone et al. Apr 2007 B2
7226440 Gelfand et al. Jun 2007 B2
7226458 Kaplan et al. Jun 2007 B2
7264587 Chin Sep 2007 B2
7294115 Wilk Nov 2007 B1
7297144 Fleischman et al. Nov 2007 B2
7309328 Kaplan et al. Dec 2007 B2
7318829 Kaplan et al. Jan 2008 B2
7331979 Khosravi et al. Feb 2008 B2
7473260 Opolski et al. Jan 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7722641 van der Burg et al. May 2010 B2
7828810 Liddicoat et al. Nov 2010 B2
7846168 Liddicoat et al. Dec 2010 B2
7905900 Palermo et al. Mar 2011 B2
7918865 Liddicoat et al. Apr 2011 B2
8157818 Gartner et al. Apr 2012 B2
8287561 Nunez et al. Oct 2012 B2
8469983 Fung et al. Jun 2013 B2
20010025132 Alferness et al. Sep 2001 A1
20020017306 Cox et al. Feb 2002 A1
20020022860 Borillo et al. Feb 2002 A1
20020049457 Kaplan et al. Apr 2002 A1
20020058925 Kaplan et al. May 2002 A1
20020062136 Hillstead et al. May 2002 A1
20020068970 Cox et al. Jun 2002 A1
20020099390 Kaplan et al. Jul 2002 A1
20020103492 Kaplan et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020111636 Fleischman et al. Aug 2002 A1
20020111637 Kaplan et al. Aug 2002 A1
20030014049 Koblish et al. Jan 2003 A1
20030024537 Cox et al. Feb 2003 A1
20030045900 Hahnen et al. Mar 2003 A1
20030069577 Vaska et al. Apr 2003 A1
20030083542 Alferness et al. May 2003 A1
20030083674 Gibbens, III May 2003 A1
20030093105 Huffmaster May 2003 A1
20030109863 Francischelli et al. Jun 2003 A1
20030120264 Lattouf Jun 2003 A1
20030158464 Bertolero Aug 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030187460 Chin et al. Oct 2003 A1
20030236535 Onuki et al. Dec 2003 A1
20040030335 Zenati et al. Feb 2004 A1
20040034347 Hall et al. Feb 2004 A1
20040044361 Frazier et al. Mar 2004 A1
20040049210 VanTassel et al. Mar 2004 A1
20040059352 Burbank et al. Mar 2004 A1
20040064138 Grabek Apr 2004 A1
20040078069 Francischelli et al. Apr 2004 A1
20040102804 Chin May 2004 A1
20040106918 Cox et al. Jun 2004 A1
20040111101 Chin Jun 2004 A1
20040116943 Brandt et al. Jun 2004 A1
20040162579 Foerster Aug 2004 A1
20040225212 Okerlund et al. Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040243176 Hahnen et al. Dec 2004 A1
20040260273 Wan Dec 2004 A1
20050033280 Francischelli et al. Feb 2005 A1
20050033287 Sra Feb 2005 A1
20050033321 Fleischman et al. Feb 2005 A1
20050043745 Alferness et al. Feb 2005 A1
20050070881 Gribbons et al. Mar 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050107824 Hillstead et al. May 2005 A1
20050149068 Williams et al. Jul 2005 A1
20050149069 Bertolero et al. Jul 2005 A1
20050154376 Riviere et al. Jul 2005 A1
20050154404 Liddicoat et al. Jul 2005 A1
20050165466 Morris et al. Jul 2005 A1
20050209627 Kick et al. Sep 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050277975 Saadat et al. Dec 2005 A1
20060004323 Chang et al. Jan 2006 A1
20060004388 Whayne et al. Jan 2006 A1
20060009715 Khairkhahan et al. Jan 2006 A1
20060020162 Whayne et al. Jan 2006 A1
20060020271 Stewart et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060034930 Khosravi et al. Feb 2006 A1
20060052750 Lenker et al. Mar 2006 A1
20060184107 Bencini et al. Aug 2006 A1
20060200169 Sniffin Sep 2006 A1
20060212045 Schilling et al. Sep 2006 A1
20060235381 Whayne et al. Oct 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060253128 Sekine et al. Nov 2006 A1
20060253129 Liddicoat et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20060270900 Chin et al. Nov 2006 A1
20060270978 Binmoeller et al. Nov 2006 A1
20060271032 Chin et al. Nov 2006 A1
20070016165 Von Oepen et al. Jan 2007 A1
20070016228 Salas Jan 2007 A1
20070027456 Gartner et al. Feb 2007 A1
20070060951 Shannon Mar 2007 A1
20070073313 Liddicoat et al. Mar 2007 A1
20070083082 Kiser et al. Apr 2007 A1
20070083225 Kiser et al. Apr 2007 A1
20070083232 Lee Apr 2007 A1
20070088369 Shaw et al. Apr 2007 A1
20070100405 Thompson et al. May 2007 A1
20070135822 Onuki et al. Jun 2007 A1
20070149988 Michler et al. Jun 2007 A1
20070179345 Santilli Aug 2007 A1
20070249991 Whayne et al. Oct 2007 A1
20070260278 Wheeler et al. Nov 2007 A1
20070270637 Takemoto et al. Nov 2007 A1
20070270891 McGuckin, Jr. Nov 2007 A1
20080009843 de la Torre Jan 2008 A1
20080033241 Peh et al. Feb 2008 A1
20080033457 Francischelli et al. Feb 2008 A1
20080039879 Chin et al. Feb 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080125795 Kaplan et al. May 2008 A1
20080147097 Liddicoat et al. Jun 2008 A1
20080221593 Liddicoat et al. Sep 2008 A1
20080228265 Spence et al. Sep 2008 A1
20080243183 Miller et al. Oct 2008 A1
20080294174 Bardsley et al. Nov 2008 A1
20080294175 Bardsley et al. Nov 2008 A1
20080312664 Bardsley et al. Dec 2008 A1
20090082797 Fung et al. Mar 2009 A1
20090143791 Miller et al. Jun 2009 A1
20090157118 Miller et al. Jun 2009 A1
20100069925 Friedman et al. Mar 2010 A1
20100174296 Vakharia et al. Jul 2010 A1
20110087247 Fung et al. Apr 2011 A1
20110144660 Liddicoat et al. Jun 2011 A1
20130144311 Fung et al. Jun 2013 A1
Foreign Referenced Citations (47)
Number Date Country
0 317 490 May 1989 EP
0 598 219-A2 A3 May 1994 EP
1 010 397 Jun 2000 EP
1 506 142 Apr 1978 GB
7-501959 Mar 1995 JP
10-502271 Mar 1998 JP
11-501837 Feb 1999 JP
11-507262 Jun 1999 JP
2001-120560 May 2001 JP
2002-540901 Dec 2002 JP
2005-110860 Apr 2005 JP
2005-531360 Oct 2005 JP
2007-504886 Mar 2007 JP
WO-9309722 May 1993 WO
WO-9401045 Jan 1994 WO
WO-9404079 Mar 1994 WO
WO-9408514 Apr 1994 WO
WO-9600531 Jan 1996 WO
WO-9628098 Sep 1996 WO
WO-9640356 Dec 1996 WO
WO-9640368 Dec 1996 WO
WO-9711644 Apr 1997 WO
WO-9743957 Nov 1997 WO
WO-9805289 Feb 1998 WO
WO-9817187 Apr 1998 WO
WO-9918878 Apr 1999 WO
WO-9918878 Apr 1999 WO
WO-0016850 Mar 2000 WO
WO-0061202 Oct 2000 WO
WO-2004002327 Jan 2004 WO
WO-2004066828-A2 Aug 2004 WO
WO-2005034767-A1 Apr 2005 WO
WO-2005034802-A2 Apr 2005 WO
WO-2006110734 Oct 2006 WO
WO-2006115689 Nov 2006 WO
WO-2006116310 Nov 2006 WO
WO-2007056502 May 2007 WO
WO-2008017080-A2 Feb 2008 WO
WO-2008036408 Mar 2008 WO
WO-2008036408 Mar 2008 WO
WO-2008091612-A2 Jul 2008 WO
WO-2008121278 Oct 2008 WO
WO-2009039191 Mar 2009 WO
WO-2009094237 Jul 2009 WO
WO-2010006061-A2 Jan 2010 WO
WO-2010048141 Apr 2010 WO
WO-2010115030 Oct 2010 WO
Non-Patent Literature Citations (273)
Entry
Advisory Action mailed on Jan. 31, 2005, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 3 pages.
Advisory Action mailed on Jan. 9, 2006, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 3 pages.
Advisory Action mailed on Feb. 6, 2006, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 2 pages.
European Communication mailed on Feb. 5, 2007, for EP Patent Application No. 00957904.6, filed on Aug. 29, 2000, 5 pages.
European Communication mailed on Aug. 8, 2007, for EP Patent Application No. 00957904.6, filed on Aug. 29, 2000, 6 pages.
European Communication mailed on Jul. 14, 2008, for EP Patent Application No. 00957904.6, filed on Aug. 29, 2000, 5 pages.
European Communication mailed on Dec. 23, 2009, for EP Patent Application No. 00957904.6, filed on Aug. 29, 2000, 6 pages.
Final Office Action mailed on Sep. 23, 2004, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 7 pages.
Final Office Action mailed on Dec. 21, 2004, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 6 pages.
Final Office Action mailed on Jan. 25, 2005, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 5 pages.
Final Office Action mailed on Feb. 10, 2005, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 7 pages.
Final Office Action mailed on Jul. 19, 2005, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 8 pages.
Final Office Action mailed on Oct. 25, 2005, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 6 pages.
Final Office Action mailed on Mar. 14, 2006, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 8 pages.
Final Office Action mailed on Nov. 1, 2006, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 6 pages.
Final Office Action mailed Aug. 31, 2011, for U.S. Appl. No. 11/944,522, filed Nov. 23, 2007, 7 pages.
International Search Report mailed on Jan. 19, 2005, for PCT Patent Application No. PCT/US03/14435, filed on May 9, 2003, 4 pages.
International Search Report mailed on Oct. 26, 2000, for PCT Application No. PCT/US2000/023727, filed on Aug. 29, 2000, 1 page.
Japanese Office Action mailed on Mar. 9, 2009.
Japanese Office Action mailed on Feb. 25, 2010, for Japanese Patent Application No. 2002-522787.
Non-Final Office Action mailed on Dec. 31, 2003, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 5 pages.
Non-Final Office Action mailed on Mar. 16, 2004, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 6 pages.
Non-Final Office Action mailed on Jun. 17, 2004, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 6 pages.
Non-Final Office Action mailed on Jun. 28, 2004, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 5 pages.
Non-Final Office Action mailed on Aug. 6, 2004, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 5 pages.
Non-Final Office Action mailed on Aug. 18, 2004, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 6 pages.
Non-Final Office Action mailed on Feb. 8, 2005, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 6 pages.
Non-Final Office Action mailed on May 11, 2005, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 7 pages.
Non-Final Office Action mailed on Jun. 2, 2005, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 4 pages.
Non-Final Office Action mailed on Jul. 20, 2005, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 6 pages.
Non-Final Office Action mailed on Feb. 16, 2006, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 6 pages.
Non-Final Office Action mailed on Mar. 29, 2006, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 8 pages.
Non-Final Office Action mailed on May 2, 2006, for U.S. Appl. No. 10/105,907, filed Mar. 25, 2002, 6 pages.
Non-Final Office Action mailed on Jul. 27, 2006, for U.S. Appl. No. 10/105,984, filed Mar. 25, 2002, 5 pages.
Non-Final Office Action mailed on Jan. 25, 2007, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 9 pages.
Non-Final Office Action mailed on Apr. 12, 2010, for U.S. Appl. No. 11/944,522, filed Nov. 23, 2007, 6 pages.
Non-Final Office Action mailed on Dec. 15, 2010, for U.S. Appl. No. 11/944,522, filed Nov. 23, 2007, 6 pages.
Notice of Allowance mailed on Aug. 15, 2006, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 7 pages.
Notice of Allowance mailed on Sep. 12, 2006, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 7 pages.
Notice of Allowance mailed on Feb. 12, 2007, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 7 pages.
Notice of Allowance mailed on Sep. 18, 2007, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 8 pages.
Supplementary European Search Report mailed on Aug. 14, 2006, for EP Patent Application No. 00957904.6, filed on Aug. 29, 2000, 6 pages.
Supplemental Notice of Allowance mailed on Oct. 6, 2006, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 9 pages.
Supplemental Notice of Allowance mailed on Oct. 6, 2006, for U.S. Appl. No. 10/105,978, filed Mar. 25, 2002, 2 pages.
Supplemental Notice of Allowance mailed on Feb. 27, 2007, for U.S. Appl. No. 10/007,364, filed Nov. 5, 2011, 4 pages.
Afibfacts.Com (Date Unknown). “Cox-Maze III: The Gold Standard Treatment for Atrial Fibrillation: Developing a Surgical Option for Atrial Fibrillation,” located at <http://www.afibfacts.com/Treatment—Options—for—Atrial—Fibrillation/Cox-Maze—Ill%—3a—The—Gold—Standard—Treatment—for—Atrial—Fibrillation , last visited on Apr. 20, 2007, 4 pages.
Al-Saady, n. M. et al. (1999). “Left Atrial Appendage: Structure, Function, and Role in Thromboembolism,” Heart82:547-554.
Albers, G.W. (Jul. 11, 1994). “Atrial Fibrillation and Stroke: Three New Studies, Three Remaining Questions,” Arch Intern Med154:1443-1448.
Alonso, M. et al, (Mar. 4, 2003). “Complications With Femoral Access in Cardiac Catheterization. Impact of Previous Systematic Femoral Angiography and Hemostasis With VasoSeal-Es®Collagen Plug,” Rev. Esp. Cardiol. 56(6):569-577.
Aronow, W.S. et al. (Apr. 2009). “Atrial Fibrillation: The New Epidemic of the Age-ing World,” Journal of Atrial Fibrillation1(6):337-361.
Babaliaros, V.C. et al. (Jun. 3, 2008). “Emerging Applications for Transseptal Left Heart Catheterization: Old Techniques for New Procedures,” Journal of the American College of Cardiology51(22):2116-2122.
Bath, P.M.W. et al. (2005). “Current Status of Stroke Prevention in Patients with Atrial Fibrillation,” European Heart Journal Supplements7(Supplement C):C12-C18.
Benjamin, B.A. et al. (1994). “Effect of Bilateral Atrial Appendectomy on Postprandial Sodium Excretion in Conscious Monkeys,” Society for Experimental Biology and Medicine2006:1 page.
Beygui, F. et al. (2005, e-pub. Oct. 21, 2005). “Multimodality Imaging of Percutaneous Closure of the Left Atrial Appendage,” Clinical Vignette, 1 page.
Bisleri, G. et al. (Jun. 3, 2005). “Innovative Monolateral Approach for Closed-Chest Atrial Fibrillation Surgery,” The Annals of Thoracic Surgery80:e22-e25.
Bjork, V.O. et al. (Aug. 1961). “Sequelae of Left Ventricular Puncture with Angiocardiography,” Circulation24:204-212.
Blackshear. J.L. et al. (Feb. 1996). “Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation,” Ann. Thorac. Surg.61(2), 13 pages.
Blackshear, J.L. et al. (Oct. 1, 2003). “Thorascopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation,” J. Am. Coll. Cardiol.42(7):1249-1252.
Bonanomi, G. et al. (Jan. 1, 2003). “Left Atrial Appendectomy and Maze,” Journal of the American College of Cardiology41(1):169-171.
Bonow, R.O. et al. (1998). “Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease),” Journal of the American Heart Association98:1949-1984.
Botham, R.J. et al. (May 1959). “Pericardial Tamponade Following Percutaneous Left Ventricular Puncture,” Circulation19:741-744.
Brock, R. et al. (1956). “Percutaneous Left Ventricular Puncture in the Assessment of Aortic Stenosis,” Thorax11:163-171.
Burke, R.P. et al. (1992). “Improved Surgical Approach to Left Atrial Appendage Aneurysm,” Journal of Cardiac Surgery7(2):104-107.
Canaccord Adams (Aug. 11, 2008). “A-Fib: Near a Tipping Point,” 167 pages.
Chung, Mx. (Jul. 2003). “Current Clinical Issues in Atrial Fibrillation,” Cleveland Clinic Journal of Medicine70(Supp. 3):56-S11.
Coffin, L.H. (Jun. 1985). “Use of the Surgical Stapler to Obliterate the Left Atrial Appendage,” Surgery, Gynecology & Obstetric160:565-566.
Connolly, S.J. (Sep. 7, 1999). “Preventing Stroke in Atrial Fibrillation: Why Are So Many Eligible Patients Not Receiving Anticoagulant Therapy?” Canadian Medical Association161(5):533-534.
Costa, R. et al. (2006). “Bi-Atrial Subxiphoid Epicardial Pacemaker in Superior Vena Cava Syndrome,” Arq. Bras. Cardiol87:e45-e47.
Cox, J.L. et al. (Apr. 1991). “The Surgical Treatment of Atrial Fibrillation: Iv. Surgical Technique,” J. Thorac. Cardiovasc. Surg.101(4):584-592.
Cox, J.L. et al. (Aug. 1995). “Modification of the Maze Procedure for Atrial Flutter and Atrial Fibrillation I. Rationale and Surgical Results,” J. Thorac. Cardiovasc. Surg.110(2):473-484.
Cox, J.L. et al. (Aug. 1995). “Modification of the Maze Procedure for Atrial Flutter and Atrial Fibrillation II Surgical Technique of the Maze III Procedure,” J. Thorac. Cardiovasc. Surg.110(2):485-495.
Cox. J.L. et al. (Nov. 1999). “Impact of the Maze Procedure on the Stroke Rate in Patients with Atrial Fibrillation.” J. Thorac. Cardiovasc. Burg.118:833-840.
Cox, J.L. et al. (2004). “The Role of Surgical Intervention in the Management of Atrial Fibrillation,” Texas Heart Institute Journal31 (3):257-265.
Crystal, E. et al. (Jan. 2003). “Left Atrial Appendage Occlusion Study (LAAOS): A Randomized Clinical Trial of Left Atrial Appendage Occlusion During Routine Coronary Artery Bypass Graft Surgery for Long-term Stroke Prevention,” Am Heart J145(1):174-178.
D'Avila, a. et al. (Apr. 2003). “Pericardial Anatomy for the Interventional Electrophysiologist,” Journal of Cardiovascular Electrophysiology14(4):422-430.
D'Avila, a. et al. (Nov. 2007). “Experimental Efficacy of Pericardial Instillation of Anti-inflammatory Agents During Percutaneous Epicardial Catheter Ablation to Prevent Postprocedure Pericarditis,” Journal of Cardiovascular Electrophysiology18(11):1178-1183.
Demaria, a.N. et al. (Dec. 17, 2003). “Highlights of the Year JACC 2003,” Journal of the American College of Cardiology42(12):2156-2166.
Deneu, S. et al. (Jul. 11, 1999). “Catheter Entrapment by Atrial Suture During Minimally Invasive Port-access Cardiac Surgery”, Canadian Journal of Anesthesia46(10):983-986.
Deponti, R. et al. (Mar. 7, 2006). “Trans-Septal Catheterization in the Electrophysiology Laboratory: Data From a Multicenter Survey Spanning 12 Years,” Journal of the American College of Cardiology47(5):1037-1042.
Donal, E. et al. (Sep. 2005). “The Left Atrial Appendage, a Small, Blind-Ended Structure: A Review of Its Echocardiographic Evaluation and Its Clinical Role,” Chest128(3):1853-1862.
Donnino, R. et al. (2007). “Left Atrial Appendage Thrombus Outside of a 'Successful' Ligation,” European Journal of Echocardiographypp. 1-2.
Dullum, M.K.C. et al. (1999). “Xyphoid MIDCAB: Report of the Technique and Experience with a Less Invasive MIDCAB Procedure,” Heart Surgery Forum2(1):77-81.
European Office Action mailed on Sep. 16, 2010, for European Patent Application No. 08727155.7, filed on Mar. 25, 2008, 5 pages.
European office Action mailed on Aug. 16, 2011, for European Patent Application No. 04794730.4, filed on Oct. 11, 2004, 7 pages.
Feinberg, W.M. et al. (Mar. 13, 1995). “Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation,” Arch Intern Med155:469-473.
Fieguth, H.G. et al. (1997). “Inhibition of Atrial Fibrillation by Pulmonary Vein Isolation and Auricular Resection—Experimental Study in a Sheep Model,” European Journal of Cardio-Thoracic Surgery11:714-721.
Final Office Action mailed on Jun. 22, 2009, for U.S. Appl. No. 10/963,371, filed on Oct. 11, 2004, 11 pages.
Final Office Action mailed on Apr. 14, 2010, for U.S. Appl. No. 11/600,671, filed on Nov. 15, 2006, 7 pages.
Final Office Action mailed on Jul. 21, 2010, for U.S. Appl. No. 11/400,714, filed on Apr. 7, 2006, 10 pages.
Final Office Action mailed on Apr. 26, 2011, for U.S. Appl. No. 12/037,802, filed on Feb. 26, 2008, 9 pages.
Final Office Action mailed on Sep. 20, 2011, for U.S. Appl. No. 12/212,511, filed on Sep. 17, 2008, 8 ages.
Final Office Action mailed on Oct. 28, 2011, for U.S. Appl. No. 12/055,213, filed on Mar. 25, 2008, 15 pages.
Final Office Action mailed on May 4, 2012, for U.S. Appl. No. 12/363,359, filed on Jan. 30, 2009, 10 pages.
Final Office Action mailed on May 16, 2012, for U.S. Appl. No. 12/363,381, filed on Jan. 30, 2009, 8 pages.
Final Office Action mailed on Jul. 11, 2012, for U.S. Appl. No. 13/033,532, filed on Feb. 23, 2011, 8 pages.
Final Office Action mailed on Jul. 24, 2012, for U.S. Appl. No. 12/212,511, filed on Sep. 17, 2008, 6 pages.
Final Office Action mailed on Oct. 18, 2012, for U.S. Appl. No. 12/124,023, filed on May 20, 2008, 15 pages.
Fisher, D.C. et al. (Dec. 1998). “Large Gradient Across a Partially Ligated Left Atrial Appendage,” Journal of the American Society of Echocardiography11(12):1163-1165.
Friberg, L. et al. (2006). “Stroke Prophylaxis in Atrial Fibrillation: Who Gets it and Who Does Not?” European Heart Journal27:1954-1964.
Friedman, P.A. et al. (Aug. 2009). “Percutaneous Epicardial Left Atrial Appendage Closure: Preliminary Results of an Electrogram Guided Approach,” Journal of Cardiovascular Electrophysiology20(8):908-915.
Fuster, V. et al. (Oct. 2001). “ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation,” European Heart Journal22(20):1852-1923.
GARC1A-Fernandez, M.A. et al. (Oct. 1, 2003). “Role of Left Atrial Appendage Obliteration in Stroke Reduction in Patients With Mitral Valve Prosthesis,” Journal of the American College of Cardiology42(7):1253-1258.
Gardiner, G.A. Jr. et al. (Apr. 1986). “Complications of Transluminal Angioplasty,” Radiology159:201-208.
Gillinov, a.M. (2007). “Advances in Surgical Treatment of Atrial Fibrillation,” Stroke38(part 2):618-623.
Gilman, R.A. et al. (Apr. 1963). “Direct Left Ventricular Puncture,” California Medicine98(4):200-203.
Goodwin, W.E. et al. (Nov. 1950). “Translumbar Aortic Puncture and Retrograde Catheterization of the Aorta in Aortography and Renal Arteriography,” Annals of Surgery132(5):944-958.
Gottlieb, L.K. et al. (Sep. 12, 1994). “Anticoagulation in Atrial Fibrillation,” Arch intern Med.154:1945-1953.
Graffigna, a. et al. (1993). “Surgical Treatment of Wolff-Parkinson-White Syndrome: Epicardial Approach Without the Use of Cardiopulmonary Bypass,” J. Card. Surg.3:108-116.
Haissaguerre, M. et al. (Nov. 2005). “Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias,” Journal of Cardiovascular. Electrophysiology16(11):1138-1147.
Halperin, J.L et al. (Aug. 1988). “Atrial Fibrillation and Stroke: New Ideas. Persisting Dilemmas,” Journal of the American Heart Association19(8):937-941.
Halperin, J.L. et al. (Oct. 1, 2003). “Obliteration of the Left Atrial Appendage for Prevention of Thromboembolism,” Journal of the American College of Cardiology42(7):1259-1261.
Hammill, S.C. (May 2006). “Epicardial Ablation: Reducing the Risks,” J. Cardiovasc. Electrophysiol.17:550-552.
Hara, H. et al. (Jan. 2008). “Percutaneous Left Atrial Appendage Obliteration,” JACC:Cardiovascular lmagin1(1):92-93.
Hart, R.G. et al. (Nov. 2, 1999). “Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention.” Annals of Internal Medicine131(9):688-695.
Hart, R.G. et al. (2001). “Atrial Fibrillation and Stroke: Concepts and Controversies,” Stroke32:803-808.
Hart, R.G. (Sep. 11, 2003). “Atrial Fibrillation and Stroke Prevention,” The New England Journal of Medicine349(11):1015-1016.
Healey, J.S. et al. (Oct. 2003). “Surgical Closure of the Left Atrial Appendage for the Prevention of Stroke: A Randomized Pilot Trial of Safety and Efficacy (The Left Atrial Appendage Occlusion Study—LAAOS),” presented at The Canadian Cardiovascular Congress 2003, Toronot, Canada, Abstract No. 666, 2 pages.
Healey, J.S. et al. (Aug. 2005). “Left Atrial Appendage Occlusion Study (LAAOS): Results of a Randomized Controlled Pilot Study of Left Atrial Appendage Occlusion During Coronary Bypass Surgery in Patients At Risk for Stroke,” American Heart Journal150(4288-293.
Hein, R. et al. (2005). “Patent Foramen Ovale and Left Atrial Appendage: New Devices and Methods for Closure,” Pediatric Cardiology26(3)234-240.
Heist, E.K. et al. (Nov. 2006). “Analysis of the Left Atrial Appendage by Magnetic Resonance Angiography in Patients with Atrial Fibrillation,” Heart Rhythm3(11):1313-1318.
Ho, I. et al. (Apr. 24, 2007). “Percutaneous Epicardial Mapping Ablation of a Posteroseptal Accessory Pathway,” Circulation115:e418-e421.
Ho. S.Y. et al. (Nov. 1999). “Anatomy of the Left Atrium: Implications for Radiofrequency Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology10(11):1525-1533.
Hoit, B.D. et al. (Jan. 1993). “Altered Left Atrial Compliance After Atrial Appendectomy. Influence on Left Atrial and Ventricular Filling,” Circulation Research72(1):167-175.
Inoue, Y. et al. (Jul.-Aug. 1997). “Video Assisted Thoracoscopic and Cardioscopic Radiofrequency Maze Ablation,” Asaio Journal43(4):334-337, Abstract Only.
International Preliminary Report on Patentability mailed on Oct. 15, 2009, for PCT Application No. PCT/US20081003938, filed on Mar. 25, 2008, 7 pages. (3.40).
International Preliminary Report on Patentability mailed on Aug. 12, 2010, for PCT Application No. PCT/US2008/076703, filed on Sep. 17, 2008, 10 pages. (4.40).
International Search Report mailed on May 19, 2008, for PCT Application No. PCT/US06/013459, filed on Apr. 7, 2006, 1 page.
International Search Report mailed on Feb. 27, 2007, for PCT Application No. PCT/US2008/003938, filed on Mar. 25, 2008, 2 pages.
International Search Report mailed on Jul. 30, 2010, for PCT Application No. PCT/US2008/076703, filed on Sep. 17. 2008, 2 pages.
International Search Report mailed on Jun. 1, 2010, for PCT Application No. PCT/US2010/029663, filed on Apr. 1, 2010, 1 page.
Jais, P. et al. (2003). “Radiofrequency Ablation for Atrial Fibrillation,” European Society of Cardiology5(Supplement H):H34-H39.
Japanese Office Action mailed on Nov. 2, 2010, for Japanese Patent Application No. 2006-534449, filed on Oct. 11, 2004, English translation included, 5 pages. (1.43).
Japanese Office Action mailed on Aug. 23, 2011, for Japanese Patent Application No. 2006-534449, filed on Oct. 11, 2004, English translation, 2 pages. (1.43).
Johnson. W.D. et al. (2000). “The Left Atrial Appendage: Our Most Lethal Human Attachment! Surgical Implications,” Euro. J. Cardiothoracic. Surg.17:718-722.
Jongbloed, M.R.M. et al. (2005). “Clinical Applications of Intracardiac Echocardiography in Interventional Procedures,” Heart91:981-990.
Kamohara, K. et al. (Aug. 2006). “Evaluation of a Novel Device for Left Atrial Appendage Exclusion: the Second-generation Atrial Exclusion Device,” The Journal of Thoracic and Cardiovascular Surgery132(2):340-346.
Kanderian, a.S. et al. (2008). “Success of Surgical Left Atrial Appendage Closure: Assessment by Transesophageal Echocardiography,” Journal of the American College of Cardiology52(11):924-929.
Kato. H. et al. (Aug. 1, 1996). “Evaluation of Left Atrial Appendage Stasis in Patients With Atrial Fibrillation Using Transesophageal Echocardiography With an Intravenous Albumin-Contrast Agent,” The American Journal of Cardiology78:365-369.
Katz, E.S. et al. (Aug. 2000). “Surgical Left Atrial Appendage Ligation is Frequently Incomplete: A Transesophageal Echocardiographic Study,” Journal of the American College of Cardiology36(2):468-471.
Kenner, H.M. et al. (Dec. 1966). “Intrapericardial, Intrapleural, and Intracardiac Pressures During Acute Heart Failure in Dogs Studied without Thoracotomy,” Circulation Research19:1071-1079.
Kerut, E.K. et al. (Jul. 2008). “Anatomy of the Left Atrial Appendage,” Echocardiography25(6):669-673.
Khargi, K. et al. (2005). “Surgical Treatment of Atrial Fibrillation: A Systematic Review,” European Journal of Cardiothoracic Surgery27:258-265.
Kim, Kb. et al. (Jan. 1998). “Effect of the Cox Maze Procedure on the Secretion of Atrial Natriuretic Peptide,” J. Thorac. Cardiovasc, Surg.115(1):139-146; discussion 146-147.
Kistler, P.M. et al. (May 2007). “The Left Atrial Appendage: Not Just an Innocent Bystander,” J. Cardiovasc Electrophysiol18(5):465-466.
Klein, H. et al. (Apr. 1990). “The Implantable Automatic Cardioverter-Defibrillator,” Herz15(2):111-125, Abstract Only.
Kolb, C. et al. (Feb. 2004). “Incidence of Antitachycardia Therapy Suspension Due to Magnet Reversion in Implantable Cardioverter Defibrillators,” Pace27:221-223.
Krikorian, J.G. et al. (Nov. 1978). “Pericardiocentesis,” Am. J. Med.65(5):808-814.
Krum, D. et al. (2004). “Visualization of Remnants of the left Atrial Appendage Following Epicardial Surgical Removal,” Heart Rhythm1:249.
Lacomis, J.M. et al. (Oct. 2003). “Multi-Detector Row CT of the Left Atrium and Pulmonary Veins before Radio-frequency Catheter Ablation for Atrial Fibrillation,” RadioGraphics 23:S35-S48.
Lacomis, J.M. et al. (2007, e-pub. Oct. 17, 2007). “Dynamic Multidimensional Imaging of the Human Left Atrial Appendage,” Europace9:1134-1140.
Lee, R. et al. (1999). “The Closed Heart MAZE: A Nonbypass Surgical Technique,” The Annals of Thoracic Surgery67:1696-1702.
Levinson, M.L. et al. (1998). “Minimally Invasive Atrial Septal Defect Closure Using the Subxyphoid Approach,” Heart Surg. Forum1(1):49-53, Abstract Only.
Lewis, D.R. et al. (1999). “Vascular Surgical Intervention for Complications of Cardiovascular Radiology: 13 Years' Experience in a Single Centre,” Ann. R. Coll. Surg. Engl.81:23-26.
Li, H. (2007). “Magnet Decoration, Beautiful But Potentially Dangerous for Patients with Implantable Pacemakers or Defibrillators,” Heart Rhythm4(1):5-6.
Lindsay, B.D. (1996). “Obliteration of the Left Atrial Appendage: A Concept Worth Testing,” The Annals of Thoracic Surgery61:515.
Lip, G.Y.H. et al. (Jun. 2001). “Thromboprophylaxis for Atrial Flutter,” European Heart Journal22(12):984-987.
Lustgarten, D.L. et al. May/Jun. 1999). “Cryothermal Ablation: Mechanism of Tissue Injury and Current Experience in the Treatment of Tachyarrhythmias,” Progress in Cardiovascular Diseases41(6):481-498.
Macris, M. et al. (Jan. 1999). “Minimally Invasive Access of the Normal Pericardium: Initial Clinical Experience with a Novel Device,” Clin. Cardiol.22(Suppl. I):1-36-1-39.
MA1SCH, B. et al. (Jan. 1999). “Intrapreicardial Treatment of Inflammatory and Neoplastic Pericarditis Guided by Pericardioscopy and Epicardial Biopsy-Results from a Pilot Study,” Clin. Cardiol.22(Supp. I):1-17-1-22.
Mannam, A.P. et al. (Apr. 1, 2002). “Safety of Subxyphoid Pericardial Access Using a Blunt-Tip Needle,” The American Journal of Cardiology89:891-893.
Mattox, K.L. et al. (May 1997). “Newer Diagnostic Measure and Emergency Management,” Ches Surg Clin N. Am.7(2)213-226, Abstract Only.
Mccarthy, P.M. et al. (2008). “Epicardial Atrial Fibrillation Ablation,” Chapter 23 in Contemporary Cardiology: Atrial Fibrillation, From Bench to Bedside, Natal, A. et al. eds., Humana Press,: Totowa, NJ, pp. 323-332.
Mccaughan, J.J. Jr., et al. (Nov. 1957). “Aortography Utilizing Percutaneous Left Ventricular Puncture,” located at <http://www.archsurg.com>, last visited on Apr. 7, 2009, 73:746-751, Abstract Only.
Mcclelland, R.R. (1978). “Congenital Aneurysmal Dilatation of the Left Auricle Demonstrated by Sequential Cardiac Blood-Pool Scintiscanning,” J. Nucl. Med.19(5):507-509.
Melo, J. et al. (Apr. 21, 2008). “Surgery for Atrial Fibrillation in Patients with Mitral Valve Disease: Results at Five Years from the International Registry of Atrial Fibrillation Surgery,” The Journal of Thoracic and Cardiovascular Surgery135(4):863-869.
Miller, P.S.J. et al. (Feb. 2005). “Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?” Stroke36:360-366.
Miyasaka, Y. et al. (Jul. 11, 2006). “Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence,” Circulation114:119-125.
Morris, J.J. Jr. (1979). “Transvenous versus Transthoracic Cardiac Pacing,” Chapter 16 in Cardiac Pacing: A Concise Guide to Clinical Practice, pp. 239-245.
Mraz. T. et al. (Apr. 2007). “Role of Echocardiography in Percutaneous Occlusion of the left Atrial Appendage,” Echocardiography24(4):401-404.
Naclerio, E.A. et al. (1979). “Surgical Techniques for Permanent Ventricular Pacing,” Chapter 10 in Cardiac Pacing: a Concise Guide to Clinical Practice, pp. 145-168.
Nakai, T. et al. (May 7, 2002). “Percutaneous Left Atrial Appendage Occlusion (PLAATO) for Preventing Cardioembolism: First Experience in Canine Model,” Circulation105:2217-2222.
Nakajima, H. et al. (2004). “Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure,” The Annals of Thoracic Surgery78:800-806.
Non-Final Office Action mailed on Aug. 6, 2008 for U.S. Appl. No. 10/963,371, filed on Oct. 11, 2004, 14 pages.
Non-Final Office Action mailed on Jun. 26, 2009, for U.S. Appl. No. 11/600,671, filed on Nov. 15, 2006, 9 pages.
Non-Final Office Action mailed on Dec. 30, 2009, for U.S. Appl. No. 11/400,714. filed on Apr. 7, 2006, 8 pages.
Non-Final Office Action mailed on Jul. 22, 2010, for U.S. Appl. No. 12/037,802, filed on Feb. 26, 2003, 10 pages.
Non-Final Office Action mailed on Nov. 15, 2010, for U.S. Appl. No. 12/055,213, filed on Mar. 25, 2008, 18 pages.
Non-Final Office Action mailed on Feb. 17, 2011, for U.S. Appl. No. 12/212,511, filed on Sep. 17, 2008, 14 pages.
Non-Final Office Action mailed on Apr. 23, 2011, for U.S. Appl. No. 12/055,213, filed on Mar. 25, 2008, 20 pages.
Non-Final Office Action mailed on Oct. 27, 2011, for U.S. Appl. No. 12/363,359, filed on Jan. 30, 2009, 11 pages.
Non-Final Office Action mailed on Nov. 9, 2011, for U.S. Appl. No. 12/363,381, filed on Jan. 30, 2009, 10 pages.
Non-Final Office Action mailed on Dec. 22, 2011, for U.S. Appl. No. 13/033,532, filed on Feb. 23, 2011, 8 pages.
Non-Final Office Action mailed on Mar. 7, 2012, for U.S. Appl. No. 12/124,023, filed on May 20, 2008, 13 pages.
Non-Final Office Action mailed on Apr. 2, 2012, for U.S. Appl. No. 12/212,511, filed on Sep. 17, 2008, 5 pages.
Notice of Allowance mailed on Sep. 17, 2010, for U.S. Appl. No. 10/963,371, filed on Oct. 11, 2004, 7 pages.
Notice of Allowance mailed on Sep. 17, 2010, for U.S. Appl. No. 11/600,671, filed on Nov. 15, 2006, 7 pages.
Notice of Allowance mailed on Nov. 24, 2010, for U.S. Appl. No. 11/400,714, filed on Apr. 7, 2006, 8 pages.
Notice of Allowance mailed on Feb. 22. 2013, for U.S. Appl. No. 12/212,511. filed on Sep. 17, 2008, 3 pages.
Notice of Allowance mailed on Mar. 18, 2013, for U.S. Appl. No. 12/212,511, filed on Sep. 17, 2003, 4 ppages
Odell, Wa. et al. (1996). “Thorascopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction?” Ann. Thorac. Surg.61:565-569.
O'Donnell, M. et al. (2005). “Emerging Therapies for Stroke Prevention in Atrial Fibrillation,” European Heart Journal 7(Supplement C):019-C27.
Omran, H. et al. (1997). “Left Atrial Appendage Function in Patients with Atrial Flutter,” Heart73:250-254.
Onalan, O. et al. (2005). “Nonpharmacologic Stroke Prevention in Atrial Fibrillation,” Expert Rev. Cardiovasc. Ther.3(4):619-633.
Onalan. O. et al. (2007). “Left Atrial Appendage Exclusion for Stroke Prevention in Patients With Nonrheumatic Atrial Fibrillation,” Stroke38(part 2):624-630.
Ostermayer, S. et al. (2003). “Percutaneous Closure of the Left Atrial Appendage,” Journal of Interventional Cardiology16(6):553-556.
Ota, T. et al. (2006). “Epicardial Atrial Ablation Using a Novel Articulated Robotic Medical Probe Via a Percutaneous Subxiphoid Approach,” National Institute of Health1(6):335-340.
Ota, T. et al. (Oct. 2007). “Impact of Beating Heart left Atrial Ablation on Left-sided Heart Mechanics,” The Journal of Thoracic and Cardiovascular Surgery134:982-988.
Pennec, P-Y. et al. (2003). “Assessment of Different Procedures for Surgical Left Atrial Appendage Exclusion,” The Annals of Thoracic Surgery76:2167-2168.
Perk, G. et al. (Aug. 2009). “Use of Real Time Three-Dimensional Transesophageal Echocardiography in Intracardiac Catheter Based Interventions,” J. Am Soc Echocardiogr22(8):365-882.
Pollick, C. (Feb. 2000). “Left Atrial Appendage Myopathy,” Chest117(2):297-308.
Poulsen. T.S. et al. (Feb. 15, 2005). “Is Aspirin Resistance or Female Gender Associated With a High Incidence of Myonecrosis After Nonurgent Percutaneous Coronary Intervention?” J. Am. Coll. Cardiol.45(4):635-636.
Reznik, G. et al. (Oct. 1992). “Percutaneous Endoscopic Implantation of Automatic Implantable Cardioverter/Defibrillator (AICD): An Animal Study of a New Nonthoracotomy Technique,” J. Laparoendosc. Surg.2(5):255-261, Abstract Only.
Robicsek, F. (1987). “Closed-Chest Decannulation of Transthoracically Inserted Aortic Balloon Catheter without Grafting,” Journal of Cardiac Surgery2(2):327-329.
Ross, J. Jr. et al. (Jun. 3, 2008). “Transseptal Left Heart Catheterization: A 50-Year Odyssey,” Journal of the American College of Cardiology51(22):2107-2115.
Rubin, D.N. et al. (Oct. 1, 1996). “Evaluation of Left Atrial Appendage Anatomy and Function in Recent-Onset Atrial Fibrillation by Transesophageal Echocardiography,” Am J Cardiol78:774-778.
Ruchat, P. et al. (2002). “Off-pump Epicardial Compartmentalization for Ablation of Atrial Fibrillation,” Interactive Cardio Vascular and Thoracic Surgery1:55-57.
Salzberg, S.P. et al. (2008). “Surgical Left Atrial Appendage Occlusion: Evaluation of a Novel Device with Magnetic Resonance Imaging,” European Journal of Cardiothoracic Surgery34:766-770.
Sapp, J. et al. (Dec. 2001). “Electrophysiology and Anatomic Characterization of an Epicardial Accessory Pathway,” Journal of Cardiovascular Electrophysiology12(12):1411-1414.
Scharf, C. et al. (2005). “Catheter Ablation for Atrial Fibrillation: Pathophysiology, Techniques, Results and Current Indications,” Continuous Medical Education8:53-61.
Scherr. D. et al. (Apr. 2009). “Incidence and Predictors of left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology20(4):379- 384.
Schmidt, H. et al. (Sep. 2001). “Prevalence of Left Atrial Chamber and Appendage Thrombi in Patients With Atrial Flutter and its Clinical Significance,” Journal of the American College of Cardiology38(3):778-784.
Schneider, B. et al. (2005, e-pub. Aug. 22, 2005). “Surgical Closure of the Left Atrial Appendage—A Beneficial Procedure?” Cardiology104:127-132.
Schweikert, R.A. et al. (Sep. 16, 2003). “Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of Previously Failed Ablation,” Circulation108:1329-1335.
Schweikert, R.A. et al. (2005). “Epicardial Access: Present and Future Applications for Interventional Electrophysiologists,” Chapter 25 in New Arrhythmia Technolgies, Wang, P.J. ed., Blackwell Publishing, pp. 242-256.
Seferovic, P. et al. (Jan. 1999). “Initial Clinical Experience with the PerDUCER® Device: Promising New Tool in the Diagnosis and Treatment of Pericardial Disease,” Ciin, Cardiol.22(Suppl):1-30-1-35.
Sengupta, P.P. et al. (2005). “Transoesophageal Echocardiography,” Heart91:541-547.
Sharada, K. et al. (2005). “Non-Surgical Transpericardial Catheter Ablation of Post-Infarction Ventricular Tachycardia,” Indian HeartJ57:58-61.
Sievert, H. et al. (Apr. 23, 2002). “Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation,” Circulation105:1887-1889.
Singer, D.E. et al. (Sep. 2004). “Antithrombotic Therapy in Atrial Fibrillation: The Seventh Accp Conference on Antithrombotic and Thrombolytic Therapy,” Chest126(31:429S-456S.
Smith, P.W. et al. (Nov. 1956). “Diagnosis of Mitral Regurgitation by Cardioangiography,” Circulation14:347-853.
Soejima, K. et al. (2004). “Subxiphoid Surgical Approach for Epicardial Catheter-Based Mapping and Ablation in Patients With Prior Cardiac Surgery or Difficult Pericardial Access,” Circulation110:1197-1201.
Sosa, E. et al. (1996). “A New Technique to Perform Epicardial Mapping in the EP Laboratory,” J. Cardiovasc. Electrophvsiol. 7(6):531-536.
Sosa, E. et al. (Mar. 1998). “Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia,” J. Cardiovasa Becytophysiol.9(3):229-239.
Sosa. E. et al. (Dec. 14, 1999). “Different Ways of Approaching the Normal Pericardial Space,” Circulation100(24);e115-e116.
Sosa, E. et al. (Jul. 15, 2002). “Gaining Access to the Pericardial Space,” The American Journal of Cardiology90:203-204.
Sosa, E. et al. (Apr. 2005). “Epicardial Mapping and Ablation Techniques to Control Centricular Tachycardia,” Journal of Cardiovasc, Electrphsioi.16(4):449-452.
Sparks, P.B. et al. (2001). “Is Atrial Flutter a Risk Factor for Stroke?” Journal of the American College of Cardiology38(3):785-788.
Spodick, D.H. (Nov. 1970). “Medical History of the Pericardium,” The American Journal of Cardiology26:447-454.
Stewart, J.M. et al. (Apr. 1992). “Bilateral Atrial Appendectomy Abolishes Increased Plasma Atrial Natriuretic Peptide Release and Blunts Sodium and Water Excretion During vol. Loading in Conscious Dogs,” Circulation Research70(4)124-732.
Stewart, S. (1974). “Placement of the Sutureless Epicardial Pacemaker Lead by the Subxiphoid Approach,” Ann. Of Thoracic Surg.13(3):303-313.
Stoddard, M.F. et al. (1995). “Left Atrial Appendage Thrombus is not Uncommon in Patients with Acute Atrial Fibrillation and a Recent Embolic Event: A Transesophageal Echocardiographic Study,” J. Am. Coil. Cardiol.25:452-459, Abstract Only.
Stokes, K. (Jun. 1990). “Implantable Pacing Lead Technology,” IEEE Engineering in Medicine and Biologypp. 43-49.
Stöllberger, C. et al. (2000). “Is the Left Atrial Appendage Our Most Lethal Attachment?” European Journal of Cardio-Thoracic Surgery18:625-626.
Stöllberger, C. et al. (Dec. 2003). “Elimination of the Left Atrial Appendage to Prevent Stroke or Embolism?: Anatomic, Physiologic, and Pathophysiologic Considerations,” 124(6):2356-2362.
Stöllberger, C. et al. (2006). “Stroke Prevention by Means of Epicardial Occlusion of the Left Atrial Appendage,” Journal of Thoracic and Cardiovascular Surgery132(1):207-208.
Stöllberger, C. et al. (2007). “Arguments Against Left Atrial Appendage Occlusion for Stroke Prevention,” Stroke38:e77.
Stöllberger, C. et al. (2007). “Leave the Left Atrial Appendage Untouched for Stroke Prevention!” Journal of Thoracic and Cardiovascular Surgery134(2):549-550.
Su, P. et al. (Sep. 2008, e-pub. May 8, 2007). “Occluding the Left Atrial Appendage: Anatomical Considerations,” Heart94(9):1166-1170.
Subramanian, V.A. (Jun. 1997). “Less Invasive Arterial CABG on a Beating Heart,” Ann. Thorac, Surg.63(6 Suppl.):368-S71.
Subramanian, V.A. et al. (Dec. 1997). “Minimally Invasive Direct Coronary Artery Bypass Grafting: two-Year Clinical Experience,” Ann. Thorac. Surg.64(6):1648-1653. Abstract Only.
Suehiro, S. et al. (1996). “Echocardiography-Guided Pericardiocentesis With a Needle Attached to a Probe,” Ann. Thoracic Surg.61:741-742.
Sun, F. et al. (Feb. 2006). “Subxiphoid Access to Normal Pericardium with Micropuncture Set: Technical Feasibility Study in Pigs,” Radiology238(2):719-724.
Szili-Torok, T. et al. (2001). “Transseptal Left heart Catheterisation Guided by Intracardiac Echocardiography.” Heart86:ell-e15.
Tabata, T. et al. (Feb. 1, 1998). “Role of Left Atrial Appendage in left Atrial Reservoir Function as Evaluated by Left Atrial Appendage Clamping During Cardiac Surgery,” The American Journal of Cardiology81:327-332.
Tomar, M. et al. (Jul.-Aug. 2006). “Transcatheter Closure of Fossa Ovalis Atrial Septa! Defect: A Single Institutional Experience,” Indian Heart Journal58(4):325-329.
Troughton, R.W. et al. (Feb. 28, 2004). “Pericarditis,” The Lancet363:717-727.
Ulicny K.S. et al, (Jun. 1992). “Conjoined Subrectus Pocket for Permanent Pacemaker Placement in the Neonate,” Ann Thorac Surg.53(6):1130-1131, Abstract Only.
Valderrabano, M. et al. (Sep. 2004). “Percutaneous Epicardial Mapping During Ablation of Difficult Accessory Pathways as an Alternative to Cardiac Surgery.” Heart Rhythm1(3):311-316.
Von Korn, H. et al. (2006). “Simultaneous Combined Interventional Percutaneous Left Atrial Auricle and Atrial Septa! Defect Closure,” Heart92:1462.
Wang, T.J. et al. (Aug. 27, 2003). “A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community,” American Medical Association290(8):1049-1056.
Watkins, L. et al. (Nov. 1982). “Implantation of the Automatic Defibrillator: The Subxiphoid Approach,” Ann. Of Thoracic Surg.34(5):515-520.
W.L. Gore & Associates (Aug. 11, 2006). “Gore Helex™ Septa! Occluder,” located at <http://www.fda.gov/cdrh/pdf5/p050006a.pdf>, last visited on Jun. 14, 2007, 3 pages.
Wolber, T. et al. (Jan. 2007). “Potential Interference of Small Neodymium Magnets with Cardiac pacemakers and Implantable Cardioverter-defibrillators,” Heart Rhythm4(1):1-4.
Wolf, P.A. et al. (Oct. 1978). “Epidemiologic Assessment of Chronic Atrial Fibrillation and Risk of Stroke: The Fiamingham Study,” Neurology28:973-977.
Wolf, P.A. et al. (Aug. 1991). “Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study,” Stroke22(8):983-988.
Wolf, P.A. et al. (Feb. 9, 1998). “Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs,” Arch Intern Med158:229-234.
Wong, J.W.W. et al. (2006). “Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes,” The Annals of Thoracic Surgery82:1938-1947.
Wongcharoen, W. et al. (Sep. 2006). “Morphologic Characteristics of the Left Atrial Appendage, Roof, and Septum: Implications for the Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology17(9):951-956.
Wood, M.A. (Jan. 2006). “Percutaneous Pericardial Instrumentation in the Electrophysiology Laboratory: A Case of Need,” Heart Rhythm3(1):11-12.
Written Opinion mailed on May 19, 2008, for PCT Application No. PCT/US06/013459, filed on Apr. 7, 2006, 6 pages.
Written Opinion of the International Searching Authority mailed on Feb. 27, 2007, for PCT Application No. PCT/US2008/003938, filed on Mar. 25, 2008, 10 pages.
Written Opinion of the International Searching Authority mailed on Jul. 30, 2010, for PCT Application No. PCT/US2008/076703, filed on Sep. 17, 2008, 8 pages.
Written Opinion of the International Searching Authority mailed on Jun. 1, 2010, for PCT Application No. PCT/US2010/029668, filed on Apr. 1, 2010, 8 pages.
Wudel, J.H. et al. (Apr. 3, 2008). “Video-Assisted Epicardial Ablation and left Atrial Appendage Exclusion for Atrial Fibrillation: Extended Follow-Up,” The Annals of Thoracic Surgery85:34-38.
Wyse. D.G. et al. (Dec. 5. 2002). “Of 'Left Atrial Appendage Amputation, Ligation, or Occlusion in Patients with Atrial Fibrillation',” N Engl J Med347(23):1825-1833, Abstract Only.
Yamada, Y. et al. (Aug. 2006). “Video-Assisted Thoracoscopy to Treat Atrial Tachycardia Arising from Left Atrial Appendage,” Journal of Cardiovascular Electrophysiology17(8):895898.
Zapolanski, a. et al. (May 2008). “Safe and Complete Exclusion of the left Atrial Appendage, A Simple Epicardial Approach,” Innovations3(3):161-163.
Zenati, M.A. et al. (Sep. 2003). “Left Heart Pacing Lead Implantation Using Subxiphoid Videopericardioscopy,” Journal of Cardiovascular Electrophysiology14(9):949-953.
Zenati, M.A. et al. (2004). “Mechanical Function of the Left Atrial Appendage Following Epicardial Bipolar Radiofrequency Ablation,” Cardiothoracic Techniques and Technologies X, Abstract 121A, p. 176.
Zenati, M.A. et al, (2005). “Modification of the Left Atrial Appendage,” Chapter 12 in Innovative Management of Atrial Fibrillation, Schwartzman, David ed., Blackwell Science Ltd., 5 pages.
Final Office Action mailed Jan. 29, 2013, for U.S. Appl. No. 11/944,522, filed on Nov. 23, 2007, 8 pages.
Non-Final Office Action mailed on Jul. 10, 2012, for U.S. Appl. No. 11/944,522, filed on Nov. 23, 2007, 8 pages.
Non-Final Office Action mailed on Mar. 13, 2008 for U.S. Appl. No. 10/963,371, filed on Oct. 11, 2004, 13 pages.
Related Publications (1)
Number Date Country
20120158022 A1 Jun 2012 US
Divisions (2)
Number Date Country
Parent 10007364 Nov 2001 US
Child 10105978 US
Parent 09315601 May 1999 US
Child 10007364 US
Continuations (2)
Number Date Country
Parent 11944522 Nov 2007 US
Child 13160441 US
Parent 10105978 Mar 2002 US
Child 11944522 US